AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 12478880 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal nicotine (5 mg/16 hrs)
Number of subjects: 10
Study 12478880 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 9785589 — intervention group
Group type: EXPERIMENTAL
Intervention: MIB‐1 staining indices (MIB‐SI, %) in meningiomas with chromosomal aberrations
Number of subjects: 10
Study 9785589 — intervention group
Group type: COMPARATOR
Intervention: MIB‐1 staining indices (MIB‐SI, %) in meningiomas without chromosomal aberrations
Number of subjects: 10
Study 9785589 — intervention group
Group type: EXPERIMENTAL
Intervention: MIB‐1 staining indices (MIB‐SI, %) in benign meningiomas
Number of subjects: 10
Study 9785589 — intervention group
Group type: EXPERIMENTAL
Intervention: MIB‐1 staining indices (MIB‐SI, %) in atypical meningiomas
Number of subjects: 10
Study 9785589 — intervention group
Group type: EXPERIMENTAL
Intervention: MIB‐1 staining indices (MIB‐SI, %) in anaplastic meningiomas
Number of subjects: 10
Study 7665718 — intervention group
Group type: EXPERIMENTAL
Intervention: Quinine sulfate (200 to 300 mg every night)
Number of subjects: 0
Study 7665718 — intervention group
Group type: COMPARATOR
Intervention: Placebo or vitamin E
Number of subjects: 0
Study 1942014 — intervention group
Group type: EXPERIMENTAL
Intervention: Vertical strip pattern of breast self-examination (BSE)
Number of subjects: 97
Study 1942014 — intervention group
Group type: EXPERIMENTAL
Intervention: Sliding finger palpation technique
Number of subjects: 97
Study 1942014 — intervention group
Group type: COMPARATOR
Intervention: Concentric circle and radial spoke patterns
Number of subjects: 97
Study 7305784 — intervention group
Group type: EXPERIMENTAL
Intervention: Conray 420 (sodium iothalamate)
Number of subjects: 200
Study 7305784 — intervention group
Group type: COMPARATOR
Intervention: Urografin 370 (methylglucamine diatrizoate with sodium diatrizoate)
Number of subjects: 200
Study 31619325 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice-daily BG testing
Number of subjects: 32
Study 31619325 — intervention group
Group type: COMPARATOR
Intervention: 4-times-daily BG testing
Number of subjects: 32
Study 29963781 — intervention group
Group type: EXPERIMENTAL
Intervention: Repaglinide (Repa group)
Number of subjects: 57
Study 29963781 — intervention group
Group type: COMPARATOR
Intervention: Sulfonylurea (SU group)
Number of subjects: 57
Study 28273933 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS (1 mA, 20 min)
Number of subjects: 40
Study 28273933 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 40
Study 26358287 — intervention group
Group type: EXPERIMENTAL
Intervention: Resuspended NPH insulin (R+)
Number of subjects: 11
Study 26358287 — intervention group
Group type: COMPARATOR
Intervention: Nonresuspended NPH insulin (R- horizontal)
Number of subjects: 11
Study 26358287 — intervention group
Group type: COMPARATOR
Intervention: Nonresuspended NPH insulin (R- up)
Number of subjects: 11
Study 26358287 — intervention group
Group type: COMPARATOR
Intervention: Nonresuspended NPH insulin (R- down)
Number of subjects: 11
Study 24898240 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholecalciferol (1200 IU/d)
Number of subjects: 130
Study 24898240 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study 24898240 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholecalciferol (1200 IU/d) excluding diabetic subjects
Number of subjects: 130
Study 22257422 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled N-acetylcysteine (NAC) 352.4 mg by inhalation twice daily
Number of subjects: 76
Study 22257422 — intervention group
Group type: COMPARATOR
Intervention: Control group (no therapy)
Number of subjects: 76
Study 22257422 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled N-acetylcysteine (NAC)
Number of subjects: 76
Study 19463133 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine RD
Number of subjects: 0
Study 19463133 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of calcium antagonists and ACE inhibitors
Number of subjects: 0
Study 19463133 — intervention group
Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 0
Study 17963316 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 0
Study 17963316 — intervention group
Group type: COMPARATOR
Intervention: Sham-acupuncture (placebo)
Number of subjects: 0
Study 15359902 — intervention group
Group type: EXPERIMENTAL
Intervention: Latanoprost (Lat)
Number of subjects: 47
Study 15359902 — intervention group
Group type: COMPARATOR
Intervention: Timolol gel-forming solution (Tg)
Number of subjects: 47
Study 11246234 — intervention group
Group type: EXPERIMENTAL
Intervention: MicroStent(R) II (MSII)
Number of subjects: 661
Study 11246234 — intervention group
Group type: COMPARATOR
Intervention: Palmaz‐Schatz (PS) stent
Number of subjects: 661
Study 9832111 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy delivery at successful target sites
Number of subjects: 332
Study 9832111 — intervention group
Group type: COMPARATOR
Intervention: Energy delivery at unsuccessful target sites
Number of subjects: 332
Study 7862918 — intervention group
Group type: COMPARATOR
Intervention: Nicotine patch delivering 0 mg per 24 h
Number of subjects: 10
Study 7862918 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine patch delivering 22 mg per 24 h
Number of subjects: 10
Study 7862918 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine patch delivering 44 mg per 24 h
Number of subjects: 10
Study 2570604 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuroleptanesthesia
Number of subjects: 21
Study 2570604 — intervention group
Group type: COMPARATOR
Intervention: Thoracic epidural anesthesia
Number of subjects: 21
Study 79761 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-trimoxazole
Number of subjects: 30
Study 79761 — intervention group
Group type: COMPARATOR
Intervention: Control (non-absorbable antibiotics)
Number of subjects: 30
Study 31742685 — intervention group
Group type: EXPERIMENTAL
Intervention: Modular cognitive-behavioral therapy (CBT) consisting of 30 sessions targeting psychotic experiences and depression/anxiety
Number of subjects: 58
Study 31742685 — intervention group
Group type: COMPARATOR
Intervention: Supportive intervention (control)
Number of subjects: 58
Study 31742685 — intervention group
Group type: EXPERIMENTAL
Intervention: Modular cognitive-behavioral therapy (CBT)
Number of subjects: 58
Study 30772851 — intervention group
Group type: EXPERIMENTAL
Intervention: Crosslinked porcine dermis mesh (Permacol)
Number of subjects: 0
Study 30772851 — intervention group
Group type: COMPARATOR
Intervention: Non-crosslinked porcine dermis mesh (Strattice)
Number of subjects: 0
Study 28853131 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-mediated health education workshop on tobacco use
Number of subjects: 0
Study 28853131 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-mediated health education workshop on nutrition/physical activity
Number of subjects: 0
Study 25871593 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensory-adapted dental environment (SADE)
Number of subjects: 44
Study 25871593 — intervention group
Group type: COMPARATOR
Intervention: Regular dental environment
Number of subjects: 44
Study 23672672 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 156
Study 23672672 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 156
Study 21426572 — intervention group
Group type: EXPERIMENTAL
Intervention: Bucco-lingual technique with professional cross-brushing five times per year
Number of subjects: 284
Study 21426572 — intervention group
Group type: COMPARATOR
Intervention: Control group with oral health education and supervised toothbrushing four times per year
Number of subjects: 284
Study 19480230 — intervention group
Group type: EXPERIMENTAL
Intervention: STD home
Number of subjects: 80
Study 19480230 — intervention group
Group type: EXPERIMENTAL
Intervention: STD+PSG lab
Number of subjects: 80
Study 19480230 — intervention group
Group type: COMPARATOR
Intervention: PSG lab
Number of subjects: 80
Study 19480230 — intervention group
Group type: COMPARATOR
Intervention: PSG+STD lab
Number of subjects: 80
Study 17086470 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted intervention (faxed physician reminders with osteoporosis treatment guidelines and patient counseling)
Number of subjects: 102
Study 17086470 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted intervention
Number of subjects: 102
Study 17086470 — intervention group
Group type: COMPARATOR
Intervention: Delayed intervention for controls (after 6 months)
Number of subjects: 102
Study 17086470 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 102
Study 15113950 — intervention group
Group type: EXPERIMENTAL
Intervention: Processed complementary food (CF)
Number of subjects: 309
Study 15113950 — intervention group
Group type: COMPARATOR
Intervention: Unprocessed placebo
Number of subjects: 309
Study 11686824 — intervention group
Group type: EXPERIMENTAL
Intervention: New dentifrice containing potassium nitrate, stannous fluoride, and sodium fluoride
Number of subjects: 186
Study 11686824 — intervention group
Group type: COMPARATOR
Intervention: Fluoride dentifrice
Number of subjects: 186
Study 11686824 — intervention group
Group type: COMPARATOR
Intervention: Sensodyne F
Number of subjects: 186
Study 9217756 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril
Number of subjects: 352
Study 9217756 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 352
Study 8424508 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural fentanyl infusion (10 micrograms/mL)
Number of subjects: 36
Study 8424508 — intervention group
Group type: COMPARATOR
Intervention: Patient-controlled analgesia (PCA) with morphine (1.0 mg/mL)
Number of subjects: 36
Study 8424508 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural fentanyl infusion
Number of subjects: 36
Study 8424508 — intervention group
Group type: COMPARATOR
Intervention: Patient-controlled analgesia (PCA) with morphine
Number of subjects: 36
Study 3621992 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% clobetasol propionate ointment applied once daily for 2 weeks
Number of subjects: 12
Study 3621992 — intervention group
Group type: COMPARATOR
Intervention: 1 week of active treatment followed by 1 week of vehicle alone
Number of subjects: 12
Study 30587217 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based group psychotherapy ("Mind it!") in addition to existing treatment regime
Number of subjects: 340
Study 27107396 — intervention group
Group type: EXPERIMENTAL
Intervention: DCYA (lipiodol-diluted cyanoacrylate)
Number of subjects: 30
Study 27107396 — intervention group
Group type: COMPARATOR
Intervention: UCYA (undiluted cyanoacrylate)
Number of subjects: 30
Study 24258302 — intervention group
Group type: EXPERIMENTAL
Intervention: SCT factors (Daydreaming)
Number of subjects: 165
Study 24258302 — intervention group
Group type: EXPERIMENTAL
Intervention: SCT factors (Sleepy/Tired)
Number of subjects: 165
Study 24258302 — intervention group
Group type: EXPERIMENTAL
Intervention: SCT factors (Working Memory Problems)
Number of subjects: 165
Study 23789780 — intervention group
Group type: EXPERIMENTAL
Intervention: Distance walked in 6 min before surgery
Number of subjects: 112
Study 23789780 — intervention group
Group type: EXPERIMENTAL
Intervention: Age of patients
Number of subjects: 112
Study 21135267 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic cranial irradiation (PCI)
Number of subjects: 0
Study 21135267 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 0
Study 18237799 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensity modulated photon radiotherapy
Number of subjects: 0
Study 18237799 — intervention group
Group type: COMPARATOR
Intervention: Proton radiotherapy
Number of subjects: 0
Study 16371493 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational shouting exercises
Number of subjects: 90
Study 16371493 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief yoga exercises
Number of subjects: 90
Study 16371493 — intervention group
Group type: COMPARATOR
Intervention: No intervention control condition
Number of subjects: 90
Study 12525460 — intervention group
Group type: EXPERIMENTAL
Intervention: Congenital uterine anomalies in women with recurrent miscarriage
Number of subjects: 2485
Study 12525460 — intervention group
Group type: COMPARATOR
Intervention: Congenital uterine anomalies in low risk women
Number of subjects: 2485
Study 12525460 — intervention group
Group type: EXPERIMENTAL
Intervention: Arcuate and subseptate uteri in recurrent miscarriage group
Number of subjects: 2485
Study 12525460 — intervention group
Group type: COMPARATOR
Intervention: Arcuate and subseptate uteri in low risk women
Number of subjects: 2485
Study 10986782 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron-fortified infant cereal (10.2 mg iron) and pureed meat (0.75-1.7 mg iron) with whole cow milk for six months
Number of subjects: 97
Study 10986782 — intervention group
Group type: COMPARATOR
Intervention: No dietary intervention (control group)
Number of subjects: 97
Study 9019575 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal mask airway (LMA)
Number of subjects: 60
Study 9019575 — intervention group
Group type: COMPARATOR
Intervention: Tracheal tube (TT)
Number of subjects: 60
Study 1732264 — intervention group
Group type: EXPERIMENTAL
Intervention: A‐V Impulse System (venous foot pump)
Number of subjects: 84
Study 1732264 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 84
Study 3840381 — intervention group
Group type: EXPERIMENTAL
Intervention: Atracurium
Number of subjects: 0
Study 3840381 — intervention group
Group type: COMPARATOR
Intervention: Alcuronium
Number of subjects: 0
Study 3840381 — intervention group
Group type: EXPERIMENTAL
Intervention: Train-of-four stimulation
Number of subjects: 0
Study 30995645 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.15% ropivacaine + 0.02 μg × kg‐1 × h‐1 DEX (group D1)
Number of subjects: 3
Study 30995645 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.15% ropivacaine + 0.05 μg × kg‐1 × h‐1 DEX (group D2)
Number of subjects: 3
Study 30995645 — intervention group
Group type: COMPARATOR
Intervention: 0.15% ropivacaine (group C)
Number of subjects: 3
Study 29120262 — intervention group
Group type: EXPERIMENTAL
Intervention: Brimonidine Tartrate Ophthalmic Solution, 0.025%
Number of subjects: 57
Study 29120262 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 57
Study 27090436 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholesterol treatment discussion
Number of subjects: 646
Study 27090436 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin prescription
Number of subjects: 646
Study 24567312 — intervention group
Group type: EXPERIMENTAL
Intervention: Eau de Dalibour (84 infants)
Number of subjects: 178
Study 24567312 — intervention group
Group type: COMPARATOR
Intervention: Ethanol (94 infants)
Number of subjects: 178
Study 21849206 — intervention group
Group type: EXPERIMENTAL
Intervention: FVIII levels determined by one-stage clotting (FVIII:C) and chromogenic (FVIII:Ch) assays; Thrombin generation measured using the Calibrated Automated Thrombogram (CAT); D-Dimer measured by immuno-turbidometric assay.
Number of subjects: 91
Study 21849206 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged anticoagulation therapy suggested for patients with high FVIII and increased TG.
Number of subjects: 91
Study 20734046 — intervention group
Group type: EXPERIMENTAL
Intervention: Gentamicin-containing collagen sponge (Collatamp(®))
Number of subjects: 161
Study 20734046 — intervention group
Group type: COMPARATOR
Intervention: No additional treatment (Control)
Number of subjects: 161
Study 18353618 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 10
Study 18353618 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 16249698 — intervention group
Group type: EXPERIMENTAL
Intervention: Probenecid (PBCD) and protease inhibitors (PIs)
Number of subjects: 0
Study 16249698 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 12728198 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychiatric treatment administered by five psychiatrists on an outpatient basis for one year.
Number of subjects: 51
Study 12728198 — intervention group
Group type: COMPARATOR
Intervention: As-usual treatment from primary care physicians.
Number of subjects: 51
Study 12728198 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychiatric treatment elsewhere (not specified).
Number of subjects: 51
Study 12728198 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment group (psychiatric treatment).
Number of subjects: 51
Study 10591045 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical acetylsalicylic acid
Number of subjects: 40
Study 10591045 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine
Number of subjects: 40
Study 7802369 — intervention group
Group type: EXPERIMENTAL
Intervention: Active compression-decompression CPR (ACD-CPR)
Number of subjects: 16
Study 7802369 — intervention group
Group type: COMPARATOR
Intervention: Standard CPR (S-CPR)
Number of subjects: 16
Study 2128228 — intervention group
Group type: EXPERIMENTAL
Intervention: Phosphatidylserine (PS) 400 mg/daily
Number of subjects: 20
Study 2128228 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 686311 — intervention group
Group type: EXPERIMENTAL
Intervention: Tubocurarine 0.05 mg/kg
Number of subjects: 45
Study 686311 — intervention group
Group type: EXPERIMENTAL
Intervention: Gallamine 0.3 mg/kg
Number of subjects: 45
Study 686311 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 45
Study 30488093 — intervention group
Group type: EXPERIMENTAL
Intervention: External Physical Vibration Lithecbole (EPVL) therapy
Number of subjects: 271
Study 30488093 — intervention group
Group type: COMPARATOR
Intervention: Control group (no EPVL therapy)
Number of subjects: 271
Study 29974219 — intervention group
Group type: EXPERIMENTAL
Intervention: MR‐HSG
Number of subjects: 40
Study 29974219 — intervention group
Group type: COMPARATOR
Intervention: X‐HSG
Number of subjects: 40
Study 28666965 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized antibiotic duration (discontinued 48 hours after clinical stability, with at least five days of total antibiotic treatment)
Number of subjects: 260
Study 28666965 — intervention group
Group type: COMPARATOR
Intervention: Standard antibiotic duration
Number of subjects: 260
Study 28666965 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized antibiotic duration
Number of subjects: 260
Study 26003508 — intervention group
Group type: EXPERIMENTAL
Intervention: MDMA (25, 50, 100 mg)
Number of subjects: 37
Study 26003508 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabis (THC 300 µg/kg)
Number of subjects: 37
Study 26003508 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocaine (HCl 300 mg)
Number of subjects: 37
Study 26003508 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 23052987 — intervention group
Group type: EXPERIMENTAL
Intervention: Caspofungin (50 mg or 70/50 mg loading dose on Day 1)
Number of subjects: 120
Study 23052987 — intervention group
Group type: COMPARATOR
Intervention: Micafungin (150 mg)
Number of subjects: 120
Study 23052987 — intervention group
Group type: EXPERIMENTAL
Intervention: Caspofungin
Number of subjects: 120
Study 23052987 — intervention group
Group type: COMPARATOR
Intervention: Micafungin
Number of subjects: 120
Study 21967254 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus (n=11) with steroids for 5 days and azathioprine (1 mg/kg) if WBC ≥ 4000 cells/cm³
Number of subjects: 41
Study 21967254 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus (n=10) with steroids for 5 days and azathioprine (1 mg/kg) if WBC ≥ 4000 cells/cm³
Number of subjects: 41
Study 21967254 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus after 2 months of Tacrolimus in Phase 2 (n=20)
Number of subjects: 41
Study 21967254 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroid-free regimen
Number of subjects: 41
Study 19567088 — intervention group
Group type: EXPERIMENTAL
Intervention: Cochlear implantation in CI recipients with GJB2 gene mutation
Number of subjects: 253
Study 19567088 — intervention group
Group type: COMPARATOR
Intervention: Cochlear implantation in CI recipients without GJB2 gene mutation (control group)
Number of subjects: 253
Study 16452698 — intervention group
Group type: COMPARATOR
Intervention: Interventions for major depressive disorder
Number of subjects: 1848
Study 15125910 — intervention group
Group type: EXPERIMENTAL
Intervention: Single auditory cue (SA)
Number of subjects: 14
Study 15125910 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitive auditory cues (RA)
Number of subjects: 14
Study 15125910 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitive cutaneous cues (RC)
Number of subjects: 14
Study 15125910 — intervention group
Group type: COMPARATOR
Intervention: No cue (NC)
Number of subjects: 14
Study 12144211 — intervention group
Group type: EXPERIMENTAL
Intervention: Foam probe cover
Number of subjects: 26
Study 12144211 — intervention group
Group type: COMPARATOR
Intervention: Hydrogel probe cover
Number of subjects: 26
Study 9669421 — intervention group
Group type: EXPERIMENTAL
Intervention: Cockcroft‐Gault estimated CrCl
Number of subjects: 118
Study 9669421 — intervention group
Group type: EXPERIMENTAL
Intervention: 24‐hour CrCl
Number of subjects: 118
Study 9669421 — intervention group
Group type: EXPERIMENTAL
Intervention: CX3 simultaneous CrCl
Number of subjects: 118
Study 9669421 — intervention group
Group type: COMPARATOR
Intervention: fGFR
Number of subjects: 118
Study 9669421 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractional excretion of creatinine
Number of subjects: 118
Study 7752827 — intervention group
Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 treatment for 4 weeks
Number of subjects: 6
Study 7752827 — intervention group
Group type: COMPARATOR
Intervention: Control conditions (placebo)
Number of subjects: 6
Study 2456618 — intervention group
Group type: COMPARATOR
Intervention: Watch and wait (limited RT if necessary)
Number of subjects: 104
Study 2456618 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggressive combined modality treatment (ProMACE-MOPP + TNI)
Number of subjects: 104
Study 25039577 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral B CrossAction Power electric toothbrush
Number of subjects: 60
Study 25039577 — intervention group
Group type: COMPARATOR
Intervention: Conventional Bitufo Class 32 soft toothbrush
Number of subjects: 60
Study 31189280 — intervention group
Group type: EXPERIMENTAL
Intervention: Pacifier use
Number of subjects: 28
Study 31189280 — intervention group
Group type: COMPARATOR
Intervention: Non-pacifier use
Number of subjects: 28